Boc-L-Ser(Bzl)-OSu

Online Inquiry

CAT#CP25332
CAS13650-73-2
Synonyms/AliasBoc-Ser(Bzl)-OSu;13650-73-2;C19H24N2O7;15079_ALDRICH;SCHEMBL2449438;15079_FLUKA;MolPort-003-926-634;NTFYOALQRQBBDG-AWEZNQCLSA-N;6444AH;ZINC71788007;AKOS025405024;AK175095;N-Boc-3-(Benzyloxy)-Ala-(succinimidyl)OH;B2205;LT03329434;N-Boc-O-benzyl-L-serineN-SuccinimidylEster;N-(tert-Butoxycarbonyl)-O-benzyl-L-serineN-SuccinimidylEster;2,5-dioxopyrrolidin-1-ylO-benzyl-N-t-butoxycarbonyl-L-serinate;(S)-2,5-Dioxopyrrolidin-1-yl3-(benzyloxy)-2-((tert-butoxycarbonyl)amino)propanoate;2,5-dioxopyrrolidin-1-yl(2S)-3-(benzyloxy)-2-[(tert-butoxycarbonyl)amino]propanoate;L-Serine,N-[(1,1-dimethylethoxy)carbonyl]-O-(phenylmethyl)-,2,5-dioxo-1-pyrrolidinylester
Chemical NameN-alpha-t-Butyloxycarbonyl-O-benzyl-L-serine succinimidyl ester
M.F/FormulaC19H24N2O7
M.W/Mr.392,41 g/mole
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 TC 14012 is a serum-stable derivative of the peptidomimetic T140, which is a cyclic peptide with the structure o ...

 MCL 0020 is a synthetic tripeptide with the structure of Ac-D-2Nal-Arg-2Nal-NH2 (2-Nal= 3-(2-naphthyl)-L-alanine ...

 Histrelin acetate, sold under many brand name like Vantas, Supprelin LA and others, is a nonapeptide analog of g ...

PT-141, also called as Bremelanotide, is a derivative for Melanotan 2 (M2). Unlike M2, PT-141 lacks C-terminal amide molecu ...

This article will give a brief introduction about atosiban and focus on its role played in the treatment of pret ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.